Patient-Reported Anxiety/Depression After Endovascular Thrombectomy: A post-hoc Analysis of Direct-MT Trial
Ping Zhang, Hong-Jian Shen, Lei Chen, Xuan Zhu, Min-Min Zhang, Yi Jiang, Peng-Fei Yang, Lei Zhang, Peng-Fei Xing, Xiao-Fei Ye, Min Lou, Cong-Guo Yin, Ben-Qiang Deng, Tao Wu, Yong-Wei Zhang, Jian-Min Liu, Ping Zhang, Hong-Jian Shen, Lei Chen, Xuan Zhu, Min-Min Zhang, Yi Jiang, Peng-Fei Yang, Lei Zhang, Peng-Fei Xing, Xiao-Fei Ye, Min Lou, Cong-Guo Yin, Ben-Qiang Deng, Tao Wu, Yong-Wei Zhang, Jian-Min Liu
Abstract
Objective: To analyze the effect of endovascular thrombectomy (EVT) alone vs. EVT after an intravenous (IV) alteplase of ischemic stroke on a patient-reported anxiety/depression, and to identify predictors of patient-reported anxiety/depression by analyzing data from Direct Intraarterial Thrombectomy in Order to Revascularize the patients with Acute Ischemic Stroke with a Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals: a Multicenter Randomized Clinical Trial (DIRECT-MT).
Methods: Patients with acute ischemic stroke (AIS), triggered by a large-vessel occlusion in the anterior circulation, were randomly allocated to undergo an EVT after IV alteplase (combination-therapy group) or an EVT alone (EVT-alone group) at a 1:1 ratio in DIRECT-MT. Patients in both groups were followed up for 90 days (±14 days) after stroke using a structured modified Ranking Scale (mRS), a Barthel Index (BI), and a 5-Dimensional European Quality of Life Scale (EQ-5D-5L). Patients who returned EQ-5D-5L were included. The EQ-5D-5L anxiety/depression dimension was used to analyze the patient-reported anxiety/depression. First, differences in patient-reported anxiety/depression were compared between the combination-therapy group and the EVT-alone group. Then, the baseline and influencing factors between the anxiety/depression group and no anxiety/depression group were analyzed using univariate regression analysis. Finally, variables with p < 0.1 in univariate regression were subjected to multivariable binary regression analysis to screen independent predictors for patient-reported anxiety /depression after ischemic stroke.
Results: : Five hundred fifteen patients returned the EQ-5D-5L in Direct-MT. Of these patients, 226 (43.88%) reported a level of anxiety/depression, and about 7% reported a severe or extremely severe anxiety/depression. The patient-reported anxiety/depression in the EVT-alone group was significantly higher than that in the combination-therapy group (48.26% vs. 39.45%, p = 0.04). The clinical outcomes were significantly different between the no Anxiety/Depression Group and the anxiety/depression group (mRS at 90 days:2 vs 3, p < 0.001; BI of 95 or 100 at 90 days: 73.36% vs 42.04%, p < 0.001; EQ-5D-5l utility indexes at 90 days:0.96 vs.57, p < 0.001). Logistic regression analysis showed that allocation to thrombolysis before EVT strategy was inversely associated with anxiety/depression [0.61(0.40, 0.94), p = 0.03], an insular cortex ischemia, and National Institute of Health Strocke Scale (NIHSS) at 7 days were positively associated with anxiety/depression [2.04(1.07, 3.90), p = 0.03; 1.07(1.03, 1.12), p < 0.001].
Conclusions: Patient-reported anxiety/depression may suggest that there is a benefit to administering intravenous alteplase before EVT. It may also indicate that it is better to provide IV alteplase before EVT, rather than EVT alone according to patient-reported anxiety/depression. Future research should consider not only the motor function impairments but also the patient-reported mental problems as measures of treatment efficacy in patients with stroke (DIRECT-MT ClinicalTrials.gov number, NCT03469206).
Keywords: anxiety; depression; ischemic stroke; thrombectomy; thrombolysis.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Copyright © 2022 Zhang, Shen, Chen, Zhu, Zhang, Jiang, Yang, Zhang, Xing, Ye, Lou, Yin, Deng, Wu, Zhang and Liu.
Figures
References
- Broomfield NM, Quinn TJ, Abdul-Rahim AH, Walters MR, Evans JJ. Depression and anxiety symptoms post-stroke/TIA: prevalence and associations in cross-sectional data from a regional stroke registry. BMC Neurol. (2014) 14:198. 10.1186/s12883-014-0198-8
- Yang P, Zhang Y, Zhang L, Zhang Y, Treurniet KM, Chen W, et al. . Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke. N Engl J Med. (2020) 382:1981–93. 10.1056/NEJMoa2001123
- Cai W, Mueller C, Li YJ, Shen WD, Stewart R. Post stroke depression and risk of stroke recurrence and mortality: a systematic review and meta-analysis. Ageing Res Rev. (2019) 50:102–9. 10.1016/j.arr.2019.01.013
- Golicki D, Niewada M, Buczek J, Karlińska A, Kobayashi A, Janssen MF, et al. . Validity of EQ-5D-5L in stroke. Qual Life Res. (2015) 24:845–50. 10.1007/s11136-014-0834-1
- Kluzek S, Dean B, Wartolowska KA. Patient-reported outcome measures (PROMs) as proof of treatment efficacy. BMJ Evid Based Med. (2021) 4:bmjebm-2020-111573. 10.1136/bmjebm-2020-111573
- Deb-Chatterji M, Konnopka A, Flottmann F, Leischner H, Fiehler J, Gerloff C, et al. . Patient-reported, health-related, quality of life after stroke thrombectomy in clinical practice. Neurology. (2020) 95:e1724–32. 10.1212/WNL.0000000000010356
- Mitchell AJ, Sheth B, Gill J, Yadegarfar M, Stubbs B, Yadegarfar M, et al. . Prevalence and predictors of post-stroke mood disorders: a meta-analysis and meta-regression of depression, anxiety and adjustment disorder. Gen Hosp Psychiatry. (2017) 47:48–60. 10.1016/j.genhosppsych.2017.04.001
- Sallinen H, Sairanen T, Strbian D. Quality of life and depression 3 months after intracerebral hemorrhage. Brain Behav. (2019) 9:e01270. 10.1002/brb3.1270
- Königsberg A, Sehner S, Arlt S, Cheng B, Simonsen CZ, Boutitie F, et al. . Effect of intravenous alteplase on post-stroke depression in the WAKE UP trial. Eur J Neurol. (2021) 28:2017–25. 10.1111/ene.14797
- Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S. The fibrinolytic system: a new target for treatment of depression with psychedelics. Med Hypotheses. (2017) 100:46–53. 10.1016/j.mehy.2017.01.013
- Han W, Dang R, Xu P, Li G, Zhou X, Chen L, et al. . Altered fibrinolytic system in rat models of depression and patients with first-episode depression. Neurobiol Stress. (2019) 11:100188. 10.1016/j.ynstr.2019.100188
- Jiang H, Chen S, Li C, Lu N, Yue Y, Yin Y, et al. . The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment. Transl Psychiatry. (2017) 7:e1079. 10.1038/tp.2017.43
- Liang J, Yue Y, Jiang H, Geng D, Wang J, Lu J, et al. . Genetic variations in the p11/tPA/BDNF pathway are associated with post stroke depression. J Affect Disord. (2018) 226:313–25. 10.1016/j.jad.2017.09.055
- Crick K, Al Sayah F, Ohinmaa A, Johnson JA. Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D-5L in assessing mental health. Qual Life Res. (2018) 27:1625–33. 10.1007/s11136-018-1828-1
Source: PubMed